Second Read and Referred S Families, Seniors and Health Committee
Summary
The bill directs the state Medicaid program (MO HealthNet) to pay for biomarker testing when it has proven clinical utility, and it obligates private insurers, nonprofit plans, and HMOs that issue contracts after August 28 2026 to do the same. It also sets up an easy‑to‑use exception process and limits the need for multiple biopsies. The measure does not require coverage for screening tests.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1795 changes status, plus AI-powered summaries and stage predictions.
Sign up free